Discontinuation report OXERVATE
| Report ID | 234791 |
| Drug Identification Number | 02485613 |
| Brand name | OXERVATE |
| Common or Proper name | CENEGERMIN |
| Company Name | DOMPÉ FARMACEUTICI S.P.A. |
| Market Status | DORMANT |
| Active Ingredient(s) | CENEGERMIN |
| Strength(s) | 0.002% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 7 X 1 ML OXERVATE MULTIDOSE GLASS VIALS |
| ATC code | S01XA |
| ATC description | |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2024-07-17 |
| Remaining supply date | 2024-06-22 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Expiry date of the last lot 21L7641 sold on the Canadian market was June 22, 2024. An official notification was submitted to Health Canada on July 31st. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | VIA SANTA LUCIA, 6 MILANO, MILAN ITALY 20122 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-08-08 | French | Compare |
| v2 | 2024-08-08 | English | Compare |
| v1 | 2024-08-08 | English | Compare |
Showing 1 to 3 of 3